Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Octavio Ramilo

Showing results (221-230 of 254) with videos related to

Pageof 26
Sort By:
Pediatric Emergency Care|February 17, 2025
Clinical Features and Management Strategies in Children With Mycoplasma PneumoniaeTamara Garcia, Todd A Florin, Jan Leonard, et al.
Contemporary Clinical Trials|July 2, 2025
Evaluation of a monoclonal antibody against respiratory syncytial virus, Clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trialsAnushua Sinha, Radha A Railkar, Luis Castagnini, et al.
The Journal of Pediatrics|August 2, 2008
Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki diseaseJane C Burns, Brookie M Best, Asuncion Mejias, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2020
Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variantRoshini S Abraham, Joanna M Marshall, Hye Sun Kuehn, et al.
The Journal of Infectious Diseases|February 2, 2018
Respiratory Syncytial Virus Seasonality: A Global OverviewPablo Obando-Pacheco, Antonio José Justicia-Grande, Irene Rivero-Calle, et al.
Nature Communications|October 23, 2014
Transcriptional specialization of human dendritic cell subsets in response to microbial vaccinesRomain Banchereau, Nicole Baldwin, Alma-Martina Cepika, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 10, 2019
Recurrent wheezing during the first 3 years of life in a birth cohort of moderate-to-late preterm infantsAntonio Moreno-Galdó, Eduardo G Pérez-Yarza, Octavio Ramilo, et al.
The Pediatric Infectious Disease Journal|March 14, 2003
Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected childrenXavier Sáez-Llorens, Avyi Violari, Carl O Deetz, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 3, 2015
Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of lifeEduardo G Pérez-Yarza, Antonio Moreno-Galdó, Octavio Ramilo, et al.
Frontiers in Pediatrics|December 15, 2023
Are the first 1,000 days of life a neglected vital period to prevent the impact on maternal and infant morbimortality of infectious diseases in Latin America? Proceedings of a workshop of experts from the Latin American Pediatric Infectious Diseases Society, SLIPERoberto Debbag, Jaime R Torres, Luiza H Falleiros-Arlant, et al.
Pageof 26

Showing results (221-230 of 254) with videos related to

Sort By:
Pageof 26
Pediatric Emergency Care|February 17, 2025
Clinical Features and Management Strategies in Children With Mycoplasma PneumoniaeTamara Garcia, Todd A Florin, Jan Leonard, et al.
Contemporary Clinical Trials|July 2, 2025
Evaluation of a monoclonal antibody against respiratory syncytial virus, Clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trialsAnushua Sinha, Radha A Railkar, Luis Castagnini, et al.
The Journal of Pediatrics|August 2, 2008
Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki diseaseJane C Burns, Brookie M Best, Asuncion Mejias, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2020
Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variantRoshini S Abraham, Joanna M Marshall, Hye Sun Kuehn, et al.
The Journal of Infectious Diseases|February 2, 2018
Respiratory Syncytial Virus Seasonality: A Global OverviewPablo Obando-Pacheco, Antonio José Justicia-Grande, Irene Rivero-Calle, et al.
Nature Communications|October 23, 2014
Transcriptional specialization of human dendritic cell subsets in response to microbial vaccinesRomain Banchereau, Nicole Baldwin, Alma-Martina Cepika, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 10, 2019
Recurrent wheezing during the first 3 years of life in a birth cohort of moderate-to-late preterm infantsAntonio Moreno-Galdó, Eduardo G Pérez-Yarza, Octavio Ramilo, et al.
The Pediatric Infectious Disease Journal|March 14, 2003
Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected childrenXavier Sáez-Llorens, Avyi Violari, Carl O Deetz, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 3, 2015
Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of lifeEduardo G Pérez-Yarza, Antonio Moreno-Galdó, Octavio Ramilo, et al.
Frontiers in Pediatrics|December 15, 2023
Are the first 1,000 days of life a neglected vital period to prevent the impact on maternal and infant morbimortality of infectious diseases in Latin America? Proceedings of a workshop of experts from the Latin American Pediatric Infectious Diseases Society, SLIPERoberto Debbag, Jaime R Torres, Luiza H Falleiros-Arlant, et al.
Pageof 26